Yan Liang
Qingdao University(CN)The University of Texas MD Anderson Cancer Center(US)Guilin Medical University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Huazhong Agricultural University(CN)Dalian University of Technology(CN)Zhengzhou University(CN)Advanced Pharma(US)Dalian University(CN)Xi'an Honghui Hospital(CN)Affiliated Hospital of Qingdao University(CN)Qingdao Municipal Hospital(CN)Institute of Wetland Research(CN)Tibet Autonomous Region People's Hospital(CN)Fu Wai Hospital(CN)Nanjing Medical University(CN)Xi'an Jiaotong University(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, RNA modifications and cancer, Ubiquitin and proteasome pathways, HER2/EGFR in Cancer Research, CRISPR and Genetic Engineering
Most-Cited Works
- → Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer(2019)699 cited
- → LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein(2018)274 cited
- → Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer(2019)211 cited
- → Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2(2017)199 cited
- → Nano‐enabled Tumor Systematic Energy Exhaustion via Zinc (II) Interference Mediated Glycolysis Inhibition and Specific GLUT1 Depletion(2021)132 cited
- → High‐mobility group box 1 released by autophagic cancer‐associated fibroblasts maintains the stemness of luminal breast cancer cells(2017)124 cited